NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/22/2023
Back to search
Official data from USPTO
PLYNRESCA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PLYNRESCA
ST13
US500000088627487Class
5, 42, 44
Filing
88627487
Registration
7145804
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
08/26/2023
Trademark type
Word
Nice classes
5, 42, 44
Filing date
09/23/2019
Registration date
08/22/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/22/2023
Last transaction
08/26/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2023-06-00
First use in commerce
2023-06-00
Drawing code
4
Owner type
03
Owner location
New York, NY
Examiner
YOUNG, CARRIE SKYE
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
BeyondSpring Pharmaceuticals, Inc.
Representatives
Ian W. Gillies KNOBBE, MARTENS, OLSON & BEAR, LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products and preparations for the prevention and treatment of cancer and side-effects from cancer therapy; pharmaceutical products and preparations for the prevention and treatment of neutropenia
Class 42
Providing scientific information and medical research information in the fields of pharmaceuticalsbiochemistrybiotechnologyclinical trials; providing scientific research and medical research information via the internet; pharmaceutical research and development services; research and development of new products; medical and scientific research in the fields of biochemistrybiotechnologyclinical trials
Class 44
Providing medical information in the fields of pharmaceuticalsbiochemistrybiotechnologyclinical trials; providing medical information via the internet
Publications
History of USPTO decisions and trademark events.
42 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/22/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/18/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/16/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/03/2023
IUAF
USE AMENDMENT FILED
06/29/2023
EISU
TEAS STATEMENT OF USE RECEIVED
06/29/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/22/2022
EX5G
SOU EXTENSION 5 GRANTED
12/21/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/21/2022
EXT5
SOU EXTENSION 5 FILED
12/08/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/08/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/21/2022
EX4G
SOU EXTENSION 4 GRANTED
06/17/2022
EXT4
SOU EXTENSION 4 FILED
06/17/2022
EEXT
SOU TEAS EXTENSION RECEIVED
06/17/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/23/2021
EX3G
SOU EXTENSION 3 GRANTED
12/21/2021
EXT3
SOU EXTENSION 3 FILED
12/21/2021
EEXT
SOU TEAS EXTENSION RECEIVED
12/21/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/03/2021
EX2G
SOU EXTENSION 2 GRANTED
07/01/2021
EXT2
SOU EXTENSION 2 FILED
07/01/2021
EEXT
SOU TEAS EXTENSION RECEIVED
07/01/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/09/2020
EX1G
SOU EXTENSION 1 GRANTED
12/07/2020
EXT1
SOU EXTENSION 1 FILED
12/07/2020
EEXT
SOU TEAS EXTENSION RECEIVED
12/07/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/12/2020
PUBO
PUBLISHED FOR OPPOSITION
05/12/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/22/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/31/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/20/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/19/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/19/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/27/2019
GNRT
NON-FINAL ACTION E-MAILED
12/27/2019
CNRT
NON-FINAL ACTION WRITTEN
12/27/2019
DOCK
ASSIGNED TO EXAMINER
12/22/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/27/2019
NWAP
NEW APPLICATION ENTERED
09/26/2019
Continuous trademark protection
Get notified about every new filing that threatens PLYNRESCA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.